IL33 and type 2 diabetes mellitus: Interestingly, conditions of T2DM such as chronic high concentrations of glucose, IL-1β, and palmitate increase IL-33 production by mesenchymal cells and disrupt the IL-33/ILC2 axis leading to less insulin secretion (35).